Clinical trial
Trastuzumab Deruxtecan in Advanced Breast Cancer
NCT07180264
Study timeline
Study start (actual)2025-08-28Date precision: day
Registry last updated2025-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Breast Cancerunresolved
Interventions
Trastuzumab deruxtecanDRUG · verified · RxNorm: trastuzumab deruxtecan
Sponsors & collaborators
Wenjin Yinlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07180264 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.